Financials data is unavailable for this security.
View more
Year on year Transmedics Group Inc grew revenues 158.53% from 93.46m to 241.62m while net income improved from a loss of 36.23m to a smaller loss of 25.03m.
Gross margin | 59.34% |
---|---|
Net profit margin | 8.14% |
Operating margin | 7.84% |
Return on assets | 4.43% |
---|---|
Return on equity | 19.41% |
Return on investment | 4.78% |
More ▼
Cash flow in USDView more
In 2023, Transmedics Group Inc increased its cash reserves by 96.01%, or 193.63m. Cash Flow from Financing totalled 400.42m or 165.72% of revenues. In addition the company used 13.03m for operations while cash used for investing totalled 193.95m.
Cash flow per share | 1.46 |
---|---|
Price/Cash flow per share | 57.21 |
Book value per share | 6.25 |
---|---|
Tangible book value per share | 5.85 |
More ▼
Balance sheet in USDView more
Current ratio | 8.20 |
---|---|
Quick ratio | 7.33 |
Total debt/total equity | 2.42 |
---|---|
Total debt/total capital | 0.7078 |
More ▼